|
|
|
Insider
Information: |
Hsiao Jane Ph D |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
49,658,203 |
|
Indirect Shares
|
33,836,183 |
|
|
Direct
Value |
$46,236,525 |
|
|
Indirect Value
|
$19,384,145 |
|
|
Total
Shares |
83,494,386 |
|
|
Total
Value |
$65,620,669 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
0
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
Percentage
Gain/Loss : |
12.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Asensus Surgical Inc |
ASXC |
Director |
2021-07-01 |
336,895 |
2021-07-01 |
96,746 |
Premium* |
|
Protalix Biotherapeutics |
PLX |
Director |
2007-01-31 |
1,134,060 |
|
0 |
Premium* |
|
Opko Health Inc |
OPK |
|
2024-01-17 |
27,999,880 |
2024-01-17 |
5,127,404 |
Premium* |
|
Prolor Biotech Inc |
PBTH |
Director |
2013-08-29 |
0 |
2013-08-29 |
0 |
Premium* |
|
Non Invasive Monitoring Systems ... |
NIMU |
Interim CEO, Director,... |
2018-12-21 |
16,752,074 |
2018-12-21 |
20,883,660 |
Premium* |
|
Sorrento Therapeutics Inc |
SRNE |
Director |
|
0 |
2010-01-25 |
2,231,719 |
Premium* |
|
Cocrystal Pharma |
COCP |
|
2016-03-15 |
3,435,294 |
2016-03-15 |
5,496,654 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2017-05-11 |
4/A |
B |
$6.92 |
$138,500 |
I/I |
20,000 |
4,677,404 |
2.66 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2017-05-11 |
4 |
B |
$6.92 |
$138,500 |
D/D |
20,000 |
24,773,133 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2024-01-17 |
4 |
B |
$0.95 |
$142,500 |
D/D |
150,000 |
27,999,880 |
0.01 |
% |
|
PBTH |
Prolor Biotech Inc |
Director |
|
2012-04-12 |
4 |
OE |
$2.50 |
$158,333 |
D/D |
63,333 |
1,874,666 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2012-10-25 |
4 |
OE |
$0.25 |
$196,346 |
I/I |
785,383 |
785,383 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-08-25 |
4 |
B |
$10.81 |
$216,325 |
D/D |
20,000 |
24,591,033 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2017-05-10 |
4/A |
B |
$6.94 |
$278,705 |
I/I |
40,000 |
4,657,404 |
2.66 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2017-05-10 |
4 |
B |
$6.94 |
$278,705 |
D/D |
40,000 |
24,753,133 |
2.81 |
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2007-01-31 |
4 |
OE |
$1.38 |
$355,496 |
D/D |
258,355 |
1,134,060 |
0 |
- |
|
PBTH |
Prolor Biotech Inc |
Director |
|
2010-05-20 |
4 |
OE |
$1.00 |
$368,523 |
I/I |
368,523 |
2,179,856 |
0 |
- |
|
PBTH |
Prolor Biotech Inc |
Director |
|
2010-05-20 |
4 |
OE |
$0.50 |
$380,000 |
D/D |
760,000 |
1,811,333 |
0 |
- |
|
NIMU |
Non Invasive Monitoring S... |
Interim CEO |
|
2018-12-21 |
4 |
B |
$0.07 |
$444,645 |
D/D |
6,352,074 |
16,752,074 |
3.23 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2010-09-10 |
4 |
OE |
$1.00 |
$477,209 |
I/I |
477,209 |
1,837,209 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2014-09-24 |
4 |
OE |
$2.48 |
$500,000 |
I/I |
201,613 |
4,472,581 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2019-10-25 |
4 |
B |
$1.50 |
$600,000 |
I/I |
400,000 |
5,127,404 |
2.66 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman and CTO |
|
2008-05-08 |
4 |
B |
$1.25 |
$625,000 |
I/I |
500,000 |
500,000 |
2.66 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2016-03-15 |
4 |
B |
$0.51 |
$630,000 |
D/D |
1,235,294 |
3,435,294 |
2.39 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2018-03-22 |
4 |
OE |
$1.65 |
$660,000 |
D/D |
400,000 |
3,562,536 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2011-01-21 |
4 |
B |
$3.55 |
$710,000 |
I/I |
200,000 |
2,564,800 |
2.66 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2017-01-04 |
4 |
OE |
$7.61 |
$856,125 |
D/D |
112,500 |
24,713,133 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2013-03-22 |
4 |
B |
$0.25 |
$1,000,000 |
D/D |
4,000,000 |
11,437,681 |
3.92 |
- |
|
NIMU |
Non Invasive Monitoring S... |
Interim CEOChairman of the Boa |
|
2013-04-08 |
4 |
B |
$0.05 |
$1,000,000 |
D/D |
20,000,000 |
10,400,000 |
3.23 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-08-06 |
4 |
OE |
$7.07 |
$1,023,899 |
I/I |
144,823 |
4,617,404 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2010-06-15 |
4 |
B |
$1.00 |
$1,300,000 |
I/I |
1,300,000 |
1,360,000 |
2.25 |
- |
|
NIMU |
Non Invasive Monitoring S... |
Interim CEO |
|
2018-12-21 |
4 |
B |
$0.07 |
$1,461,856 |
I/I |
20,883,660 |
20,883,660 |
2.64 |
- |
|
93 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|